Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue
Presented on 14 September 2021
Tuesday 14th September 2021 | 12.30pm EDT | 5.30pm UK
Kathryn C Fitzgerald, Bridget Morris, Aurash Soroosh, Alexandra Balshi, Dermot Maher, Adam Kaplin, Bardia Nourbakhsh.
Mult Scler. 2021 May;27(6):942-953. doi: 10.1177/1352458520936226. Epub 2020 Jul 7. PMID: 32633662; PMCID: PMC7790846.
Presenter: Bardia Nourbakhsh, MD, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.